Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study
- PMID: 30904777
- DOI: 10.1016/j.jad.2019.03.007
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study
Abstract
Background: Few studies have examined the prevalence and correlates of subsyndromal and syndromal depressive symptoms (SSSD) among older adults with schizophrenia spectrum disorder. In this report, we examined the prevalence of SSSD and their associations with sociodemographic characteristics, clinical characteristics of schizophrenia, comorbidity, psychotropic medications, quality of life, functioning and mental health care utilization in a large, multicenter sample of older adults with schizophrenia spectrum disorder.
Methods: Data from the Cohort of individuals with Schizophrenia Aged 55 years or more (CSA) were used to examine the prevalence of SSSD, defined using the Center of Epidemiologic Studies Depression (CESD) scale. Clinical characteristics associated with SSSD were explored.
Results: Among 343 older adults with schizophrenia spectrum disorder, 78.1% had either subsyndromal (30.6%) or syndromal (47.5%) depressive symptoms. SSSD were independently associated with positive and negative symptoms, lower quality of life, non-late-onset psychosis, benzodiazepine use and urbanicity. There were no significant associations of SSSD with other sociodemographic characteristics and psychotropic medications, or with general medical conditions. We found no significant differences in the proportion of participants who were treated with antidepressants between those with syndromal depressive symptoms and those without depression (22.1% vs. 20.0%, p = 0.89). SSSD were not associated with higher mental health care utilization.
Limitations: Data were cross-sectional and depression was not evaluated with a semi-structured interview.
Conclusion: SSSD may be highly prevalent and under-assessed and/or undertreated among older adults with schizophrenia spectrum disorder. Our findings should alert clinicians about the need to assess systematically and regularly depression in this vulnerable population.
Keywords: Antidepressants; Antipsychotic; Depression; Depressive symptoms; Elderly; Older; Prevalence; Risk factors; Schizophrenia; Treatment.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
A Longitudinal Study of the Outcome and Associated Factors of Subsyndromal and Syndromal Depression in Community-Dwelling Older Adults with Schizophrenia Spectrum Disorder.Am J Geriatr Psychiatry. 2015 Sep;23(9):925-33. doi: 10.1016/j.jagp.2014.06.011. Epub 2014 Jul 2. Am J Geriatr Psychiatry. 2015. PMID: 25113720
-
Effects of depression and cognitive impairment on quality of life in older adults with schizophrenia spectrum disorder: Results from a multicenter study.J Affect Disord. 2019 Sep 1;256:164-175. doi: 10.1016/j.jad.2019.05.063. Epub 2019 May 28. J Affect Disord. 2019. PMID: 31176189
-
Benzodiazepine use among older adults with schizophrenia spectrum disorder: prevalence and associated factors in a multicenter study.Int Psychogeriatr. 2020 Apr;32(4):441-451. doi: 10.1017/S1041610219000358. Epub 2019 May 7. Int Psychogeriatr. 2020. PMID: 31062670
-
Co-occurring depressive symptoms in the older patient with schizophrenia.Drugs Aging. 2008;25(8):631-47. doi: 10.2165/00002512-200825080-00002. Drugs Aging. 2008. PMID: 18665657 Free PMC article. Review.
-
Treatment of schizoaffective disorder and schizophrenia with mood symptoms.Am J Psychiatry. 1999 Aug;156(8):1138-48. doi: 10.1176/ajp.156.8.1138. Am J Psychiatry. 1999. PMID: 10450252 Review.
Cited by
-
Excess mortality and its causes among older adults with schizophrenia versus those with bipolar disorder and major depressive disorder: a 5-year prospective multicenter study.Eur Arch Psychiatry Clin Neurosci. 2024 Jan 31. doi: 10.1007/s00406-023-01752-1. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38294521
-
Depression severity mediates stigma and quality of life in clinically stable people with schizophrenia in rural China.BMC Psychiatry. 2023 Nov 11;23(1):826. doi: 10.1186/s12888-023-05355-x. BMC Psychiatry. 2023. PMID: 37951892 Free PMC article.
-
Study on correlations of BDNF, PI3K, AKT and CREB levels with depressive emotion and impulsive behaviors in drug-naïve patients with first-episode schizophrenia.BMC Psychiatry. 2023 Apr 3;23(1):225. doi: 10.1186/s12888-023-04718-8. BMC Psychiatry. 2023. PMID: 37013544 Free PMC article.
-
Physical activity levels associated with insomnia and depressive symptoms in middle-aged and elderly patients with chronic schizophrenia.Front Psychiatry. 2023 Jan 6;13:1045398. doi: 10.3389/fpsyt.2022.1045398. eCollection 2022. Front Psychiatry. 2023. PMID: 36683978 Free PMC article.
-
Psychiatric symptoms and mortality in older adults with major psychiatric disorders: results from a multicenter study.Eur Arch Psychiatry Clin Neurosci. 2023 Apr;273(3):627-638. doi: 10.1007/s00406-022-01426-4. Epub 2022 Jun 20. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35723739
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
